Bin Huang
Directeur/Bestuurslid bij 3SBIO INC.
Vermogen: 25 M $ op 31-05-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jing Lou | M | 61 |
Taizhou Huan Sheng Investment Management Co., Ltd.
Collected Mind Ltd.
 Collected Mind Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Collected Mind Ltd. functions as an investment holding There is no available country named vg company.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 jaar |
| Bo Tan | M | 51 |
Collected Mind Ltd.
Collected Mind Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Collected Mind Ltd. functions as an investment holding There is no available country named vg company.
Taizhou Huan Sheng Investment Management Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 15 jaar |
| Dong Mei Su | M | 54 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 jaar |
| Tian Ruo Pu | M | 55 | 11 jaar | |
| Hui Dang | F | 52 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 25 jaar |
| Ke Li | M | 56 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 jaar |
| Joo Yeow Ng | M | 59 | 2 jaar | |
| Siu Kuen Lai | F | 48 | 7 jaar | |
| Hui Hui Li | F | 43 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 11 jaar |
| Xin Ma | M | 58 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | - |
| Hoi Ti Yang | F | 54 | 3 jaar | |
| Dan Zhang | M | 60 | 2 jaar | |
| Yong Fu Chen | M | 67 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 21 jaar |
| Dong Tao Luo | M | 48 | 8 jaar | |
| Yuan Yuan Ren | M | - | - | |
| Xiang He | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Dan Lou | M | 89 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 19 jaar |
| David Parkinson | M | 73 | 7 jaar | |
| Dong Liu | M | 51 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 6 jaar |
| Lap Yan Wong | M | 53 | 3 jaar | |
| Rui Wang | M | 60 | - | |
| Zhonghua Zhang | M | 49 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | - |
| Lawrence S. Wizel | M | 81 | - | |
| Dong Lü | M | 49 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 3 jaar |
| Ying Fei Wei | M | 63 | - | |
| Jun Ma | M | 61 | 5 jaar | |
| Mou Jia Qi | M | 91 | - | |
| Pei Guo Cong | M | 69 | - | |
| Ming De Yu | M | 78 | - | |
| Yan Li Liu | F | 43 | 3 jaar | |
| Liping Xu | F | - | - | |
| David Chen | M | 59 | 4 jaar | |
| Kwok Fai Lee | M | - | 1 jaar | |
| Fei Wang | M | 47 | 3 jaar | |
| Suet Wing Leung | F | 35 | 3 jaar | |
| Thomas Folinsbee | M | 57 | 10 jaar | |
| Da Song Wang | M | 55 | 2 jaar | |
| Zhen Ping Zhu | M | 59 | 2 jaar | |
| Wei Hong Xiao | M | 56 | 3 jaar | |
| Ke Tang | M | 45 | 2 jaar | |
| Fei You | F | 45 | 7 jaar | |
| Clara Mak | F | - | - | |
| Guanjin Hu | M | - | - | |
| Min Jia | M | 53 | 4 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| China | 44 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
